Compare PRTA & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTA | RYAM |
|---|---|---|
| Founded | 2012 | 1926 |
| Country | Ireland | United States |
| Employees | N/A | 2325 |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.3M | 491.8M |
| IPO Year | 2013 | 2014 |
| Metric | PRTA | RYAM |
|---|---|---|
| Price | $9.73 | $10.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $19.00 | $14.00 |
| AVG Volume (30 Days) | 383.0K | ★ 1.1M |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $814,000.00 | ★ $1,466,397,000.00 |
| Revenue This Year | $1,111.38 | $5.46 |
| Revenue Next Year | N/A | $8.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.32 | $3.35 |
| 52 Week High | $14.60 | $11.05 |
| Indicator | PRTA | RYAM |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 66.57 |
| Support Level | $9.54 | $7.09 |
| Resistance Level | $10.72 | N/A |
| Average True Range (ATR) | 0.58 | 0.74 |
| MACD | 0.12 | 0.18 |
| Stochastic Oscillator | 75.99 | 93.53 |
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.